- The Issue
- The Solutions
- News & Media
- Case Studies
- Policy Center
An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For journalists and other media professionals
Last week, PIPC Chairman Tony Coelho sat down with the Sudden Cardiac Arrest Association (SCAA) to talk about comparative effectiveness research (CER) and how this research and other aspects of health reform will affect patients.
PIPC will be keeping a close eye on the Senate Finance Committee’s work on health reform legislation today. The Committee is expected to discuss possible revisions to the comparative effectiveness research language already in the proposed legislation. Recently, PIPC issued a statement in support of the language in the Chairman Baucus’s bill.
PIPC remains optimistic that patient-centered comparative effectiveness research (CER) will be included in health reform legislation, despite its disappointment that the House Energy and Commerce Committee did not act on the bi-partisan patient-centered CER amendment during their work last week.